• Home
  • Blog

Call us today! +1 (352) 353-0052

Find our Location
info@derivatixcapital.com
Login

Login
Derivatix Capital ManagementDerivatix Capital Management
  • Home
  • Blog

Fundamentals of Options Seminar, Mar. 10, 2023

Fundamentals of Options Seminar, Mar. 10, 2023

Fundamentals of Options Seminar, Mar. 10, 2023

March 8, 2023 Event

During our last info sessions in Sep. 2020, I personally enjoyed audience contributions and good questions. We had a great conversation and engagement with them. Here is a sample comment I received on the event from my long-term friend, Dr. Rasti: “As general feedback on your session, I think it was very engaging, easy to follow, and full of useful information. You hit on very good points.”

As per participants’ interest and request to provide more educational materials on the topic, we are planning a few webinar series and courses to practically transfer knowledge and skills. I always compare a successful trader to a great surgent. You can’t be a great surgent overnight by reading the “How to surgery for dummies” book or taking a few courses. You need years of practice under the supervision of a senior professional surgent. Trading is the same, you need years of deep thinking, practical courses, and learning by doing. There is not any shortcut at all for sustainable profit in trading.

Here you can register for the free pre-season course. Seats are limited. It is the prerequisite to the main long course series.

Register in advance for this webinar:
Zoom link to be added

After registering, you will receive a confirmation email containing information about joining the course.

See you,

Maziyar Yousefizad,

Fund Manager

Share
0

You also might be interested in

Derivatix Quarterly Report: Mid 2020-Q1 as of Feb. 29th, 2020

Derivatix Quarterly Report: Mid 2020-Q1 as of Feb. 29th, 2020

Mar 6, 2020

While the world is fighting against the coronavirus pandemic, don’t[...]

Derivatix Monthly Report: Month 30 & 31 as of Mar. 31st, 2018

Apr 23, 2018

A wise man once said; don’t wake up the monster[...]

Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021

Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021

Jul 15, 2021

2021-Q2 Market Summary*: U.S. equity benchmarks closed the first half[...]

Recent Posts

  • Fundamentals of Options Seminar, Mar. 10, 2023
  • Derivatix Quarterly Report: 2022-Q4 as of Dec. 31, 2022
  • Derivatix Quarterly Report: 2022-Q2 as of Sep. 30th, 2022
  • Derivatix Quarterly Report: 2022-Q2 as of Jun. 30th, 2022
  • Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
  • Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021
  • Derivatix Quarterly Report: 2021-Q2 as of Sep. 30th, 2021
  • Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021

Recent Comments

    Archives

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent Comments

    Find us on

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Send Message

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.

    Contact Info

    • Derivatix Capital Management
    • +1 (352) 353-0052
    • info@derivatixcapital.com
    • derivatixcapital.com

    Fresh from blog

    • Fundamentals of Options Seminar, Mar. 10, 2023
    • Derivatix Quarterly Report: 2022-Q4 as of Dec. 31, 2022
    • Derivatix Quarterly Report: 2022-Q2 as of Sep. 30th, 2022
    • Derivatix Quarterly Report: 2022-Q2 as of Jun. 30th, 2022
    • Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
    • Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021

    © 2023 — Derivatix Capital Management.

    • Home
    • Blog
    Prev

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.